Previous studies have shown that gouty nephropathy is associated with the TLR4/MyD88/NF-κB signaling pathway and that active substances can inhibit GN by modulating the TLR4/MyD88/NF-κB signaling pathway (Hao et al., 2023). Here, MYD88 is linked to ganglioneuroma.